<code id='3322D7243E'></code><style id='3322D7243E'></style>
    • <acronym id='3322D7243E'></acronym>
      <center id='3322D7243E'><center id='3322D7243E'><tfoot id='3322D7243E'></tfoot></center><abbr id='3322D7243E'><dir id='3322D7243E'><tfoot id='3322D7243E'></tfoot><noframes id='3322D7243E'>

    • <optgroup id='3322D7243E'><strike id='3322D7243E'><sup id='3322D7243E'></sup></strike><code id='3322D7243E'></code></optgroup>
        1. <b id='3322D7243E'><label id='3322D7243E'><select id='3322D7243E'><dt id='3322D7243E'><span id='3322D7243E'></span></dt></select></label></b><u id='3322D7243E'></u>
          <i id='3322D7243E'><strike id='3322D7243E'><tt id='3322D7243E'><pre id='3322D7243E'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:6567
          A pair of scissor cuts four paper figures from a line of them — biotech coverage from STAT
          Adobe

          Sonata Therapeutics, a startup created two years ago through the merger of two Flagship Pioneering companies, has laid off about a third of its staff.

          The biotech laid off 21 employees in recent weeks, according to employee posts on social media and a company spokesperson. Sonata had around 63 employees before the layoffs.

          advertisement

          Sonata is just the latest in a series of startups laying off employees in order to stretch out their cash runways. Privately held startups have had a difficult time raising money during the recent biotech downturn, which has shown signs of abating in the last few months. But at this point, startups are still finding that private investors and venture capitalists are being cautious with their money as they wait to see if the downturn is truly over.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024
          JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

          EricTokatisco-presidentofinvestmentbankingatCenterviewPartners.CourtesyCenterviewPartnersSANFRANCISC

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

          PhotobyKEREMYUCEL/AFPviaGettyImagesSANFRANCISCO—MayoClinichassignedSiliconValleytechstartupCerebrasa